In this episode of the FCPA Compliance Report, I visit Michael DeBernardis, Counsel at Hughes Hubbard. We discuss the Trump Administration’s China Initiative and how it may impact FCPA enforcement efforts and spark a potential backlash against US companies. Some of the highlights include:

1. What is the China Initiative?
2. Why is it significant?
3. What developments have you seen over the past 6 months since its announcement?
4. Does the China Initiative tie into the effort for greater transparency of Chinese owned companies in America per the Senate bill on auditing?
5. Does the China Initiative mean the FCPA is being weaponized? If so, what are the implications?
6. What about China push back? FedEx or even GSK?

You can find more information on see DeBernardis and Zygielbaum’s article  Revisiting the China Initiative: Will the Focus on FCPA Prosecutions of Chinese Companies Produce Results?